Drugs / ACHN-789
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03163550 | May → Oct 2017 | — | Achaogen, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ACHN-789 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03163550 ↗ |
| Route | Oral | “Oral dose” NCT03163550 ↗ |